Vitrolife's Annual Reports

Vitrolife Group is listed on Nasdaq Stockholm and is a world leader in products and systems for the IVF market. Their annual report serves both a financial and a scientific audience — institutional investors and healthcare professionals who expect accuracy on both counts.

Fluid Translation has supported Vitrolife's annual report production, handling Swedish–English translation of the complete statutory report: financial statements prepared under IFRS, notes, management commentary, sustainability disclosures, and corporate governance statements.

The intersection of medical technology and financial reporting requires a translator team with dual specialisation. Our translators combine deep knowledge of IFRS financial reporting with familiarity with IVF and medtech terminology — ensuring that clinical terms are handled correctly alongside financial language.

We manage Vitrolife's translation workstream within their annual reporting calendar, coordinating with their IR team and design agency to ensure the English-language report is available for simultaneous publication with the Swedish version.

Vitrolife's annual reports are models of the kind of integrated financial and sustainability reporting that we do best — complex, regulated, with a global readership that demands the highest quality. See also our AFRY case study for another example of large-scale annual report translation.